Skip to main content
. Author manuscript; available in PMC: 2021 May 18.
Published in final edited form as: Am J Transplant. 2020 Jan 22;20(5):1439–1446. doi: 10.1111/ajt.15756

TABLE 4.

Two time-window Cox proportional hazards model (early and late PTLD)

Hazard ratio Confidence interval P value
≤365 d
 IPF 2.14 [0.98–9.77] .327
 EBV mismatch 102.30 [30.37–344.49] <.0001
 Alemtuzumab 3.39 [1.03–11.14] .044
>365 d
 IPF 4.56 [1.29–16.16] .019
 EBV mismatch 4.01 [0.51–31.69] .187
 Alemtuzumab 1.24 [0.33–4.71] .326

Abbreviations: EBV, Epstein-Barr virus; IPF, idiopathic pulmonary fibrosis; PTLD, posttransplant lymphoproliferative disorder.